A new subgroup analysis reveals that adolescents with moderate-to-severe plaque psoriasis treated with once-daily icotrokinra ...

Compared with adalimumab, several biologic medications had superior safety profiles for the treatment of moderate to severe psoriasis.

Icotrokinra was safe and effective for improving skin clearance among patients with at least moderate psoriasis in high-impact areas.

However, this new study, led by researcher Hye Sun Gwak, reviewed data from 13 different studies and found that some of these ...

Psoriasis reacts differently for each person. You could find that particular behaviors or situations cause your psoriasis to flare, even for something that’s not well recognized as a trigger.

Deucravacitinib met its primary endpoint of more than 20% improvement in ACR20 response among patients with psoriatic ...

Patients with psoriatic arthritis (PsA) have a higher prevalence of diabetes mellitus (DM) compared to the general population ...

Stress significantly impacts skin health, potentially triggering conditions like acne, eczema, and psoriasis. Stress hormones ...

A rare case of adalimumab-induced pustular psoriasis in a hidradenitis suppurativa patient was successfully treated with ...

The autoimmune disease causes raised, scaly patches of skin. As a child, it left the football star embarrassed to remove his ...

Psoriasis affects your body’s immune system, causing it to produce too many skin cells. Those extra cells build up and create a flaky rash that may appear red, purple, ashen gray, or brown ...

Discover a study that found that following surgery, 97.2% of patients experienced a reduction in psoriasis severity to mild ...